Page last updated: 2024-11-12

tachioside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tachioside: from the linseed meal; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11962143
CHEMBL ID1077078
SCHEMBL ID9576060
MeSH IDM000613898

Synonyms (12)

Synonym
tachioside
CHEMBL1077078
(2s,3r,4s,5s,6r)-2-(4-hydroxy-3-methoxy-phenoxy)-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
109194-60-7
SCHEMBL9576060
1-o-(4-hydroxy-3-methoxyphenyl)-beta-d-glucopyranose
4-hydroxy-3-methoxyphenol beta-d-glucopyranoside
AKOS032948097
(2s,3r,4s,5s,6r)-2-(4-hydroxy-3-methoxyphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-(4-hydroxy-3-methoxyphenoxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
F92965
FS-10122
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1187909Antioxidant activity assessed as copper(I)ion reduction power at 10 uM after 1 hr by cupric ion reducing antioxidant capacity assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
A new phenylpropanoid and an alkylglycoside from Piper retrofractum leaves with their antioxidant and α-glucosidase inhibitory activity.
AID1187910Metal chelating activity of the compound assessed as Cu2+ chelating activity at 10 uM by fluorescence assay relative to control2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
A new phenylpropanoid and an alkylglycoside from Piper retrofractum leaves with their antioxidant and α-glucosidase inhibitory activity.
AID470165Antiestrogenic activity in human MCF7 cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 1 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID470168Antiestrogenic activity in human T47D cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 1 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1187907Antioxidant activity assessed as trolox equivalent of AAPH radical scavenging activity at 10 uM after 2 mins by ORAC-RCoo assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
A new phenylpropanoid and an alkylglycoside from Piper retrofractum leaves with their antioxidant and α-glucosidase inhibitory activity.
AID1187908Antioxidant activity assessed as copper(I)ion reduction power at 1 uM after 1 hr by cupric ion reducing antioxidant capacity assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
A new phenylpropanoid and an alkylglycoside from Piper retrofractum leaves with their antioxidant and α-glucosidase inhibitory activity.
AID470163Antiestrogenic activity in human MCF7 cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 50 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID470161Stimulation of human MCF7 cell proliferation up to 100 uM after 96 hrs by alamar blue assay relative to estradiol2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1187905Inhibition of alpha-glucosidase (unknown origin) using 3 mM p-NPG solution at 50 uM relative to control2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
A new phenylpropanoid and an alkylglycoside from Piper retrofractum leaves with their antioxidant and α-glucosidase inhibitory activity.
AID470162Stimulation of human T47D cell proliferation up to 100 uM after 96 hrs by alamar blue assay relative to estradiol2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1187906Antioxidant activity assessed as trolox equivalent of AAPH radical scavenging activity at 1 uM after 2 mins by ORAC-RCoo assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
A new phenylpropanoid and an alkylglycoside from Piper retrofractum leaves with their antioxidant and α-glucosidase inhibitory activity.
AID470166Antiestrogenic activity in human T47D cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 50 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID470167Antiestrogenic activity in human T47D cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 10 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID470164Antiestrogenic activity in human MCF7 cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 10 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.28 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]